What is the average price target for INVENTIVA SA - ADR (IVA) stock?
16 analysts have analysed IVA and the average price target is 14.89 USD. This implies a price increase of 165.81% is expected in the next year compared to the current price of 5.6.
INVENTIVA SA - ADR (IVA) Forecast, Price Target & Analyst Ratings
NASDAQ:IVA • US46124U1079
Current stock price
5.6 USD
+0.09 (+1.63%)
Last:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for INVENTIVA SA - ADR (IVA).
Forecast Snapshot
Price Target Details & History
Consensus Price Target and Range
Mean target
$14.89
Upside
+ 165.81%
From current price of $5.60 to mean target of $14.89, Based on 16 analyst forecasts
Low
$8.23
Median
$12.98
High
$27.28
Price Target Revisions
1 Month
-5.76%
3 Months
5.96%
Price Target Summary
16 Wall Street analysts provided a forecast for the next 12 months for IVA. The average price target is 14.89 USD. This implies a price increase of 165.81% is expected in the next year compared to the current price of 5.6.
The average price target has been revised upward by 5.96% in the past 3 months.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
88.75%
IVA was analyzed by 16 analysts. The buy percentage consensus is at 89. So analysts seem to be very confident about IVA.
In the previous month the buy percentage consensus was at a similar level.
IVA was analyzed by 16 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-19 | Truist Securities | Initiate | Buy |
| 2026-01-28 | Barclays | Initiate | Overweight |
| 2026-01-12 | Leerink Partners | Initiate | Outperform |
| 2025-11-18 | Guggenheim | Maintains | Buy -> Buy |
| 2025-11-06 | Wolfe Research | Initiate | Outperform |
| 2025-10-09 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-09-30 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2025-09-02 | Guggenheim | Maintains | Buy -> Buy |
| 2025-08-27 | Piper Sandler | Initiate | Overweight |
| 2025-04-04 | Guggenheim | Maintains | Buy -> Buy |
| 2025-04-02 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-03-28 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-01-30 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-11-22 | Stifel | Maintains | Buy -> Buy |
| 2024-11-12 | UBS | Initiate | Neutral |
| 2024-10-15 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-09-26 | Stifel | Maintains | Buy -> Buy |
| 2024-09-26 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-04-08 | Canaccord Genuity | Maintains | Buy -> Buy |
| 2024-04-01 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-20 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-03-08 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2024-02-16 | Stifel | Maintains | Buy -> Buy |
| 2023-12-21 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2023-10-27 | Canaccord Genuity | Initiate | Buy |
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- May 25, 2026
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates 2026 - 2033
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 17.477M 43.50% | 9.198M -47.37% | 4.483M -51.26% | 1.916M -57.26% | 22.268M 1,062.21% | 108.1M 385.45% | 285.89M 164.47% | 580.35M 103.00% | 869.75M 49.87% | 1.057B 21.53% | 1.288B 21.85% | |
| EBITDA YoY % growth | -100.066M -81.41% | -90.311M 9.75% | N/A -14.09% | -114.045M -10.69% | -98.596M 13.55% | -47.573M 51.75% | -13.25M 72.15% | 281.69M 2,225.99% | 433.78M 53.99% | 597.02M 37.63% | 775.08M 29.82% | |
| EBIT YoY % growth | -102.665M -80.57% | -95.509M 6.97% | -141.013M -47.64% | -121.321M 13.96% | -130.8M -7.81% | -75.452M 42.31% | 52.968M 170.20% | 310.64M 486.47% | 592.67M 90.79% | 803.3M 35.54% | 1.133B 41.04% | |
| Operating Margin | -587.43% | -1,038.37% | -3,145.51% | -6,332.02% | -587.39% | -69.80% | 18.53% | 53.53% | 68.14% | 76.00% | 87.97% | |
| EPS YoY % growth | N/A -27.70% | N/A -24.50% | N/A 31.57% | -1.17 40.18% | -1.46 -24.25% | -0.78 46.51% | -0.35 54.97% | 3.38 1,062.93% | 6.70 98.47% | 2.16 -67.81% | N/A |
All data in EUR
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in EUR
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
17.02%
EPS Next 5 Year
30.08%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
145.04%
Revenue Next 5 Year
139.62%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
16.18%
EBIT Next 5 Year
35.44%
INVENTIVA SA - ADR / IVA Forecast FAQ
Can you provide the upcoming earnings date for INVENTIVA SA - ADR?
INVENTIVA SA - ADR (IVA) will report earnings on 2026-05-25.
What is the expected long term growth rate for IVA stock?
The expected long term growth rate for INVENTIVA SA - ADR (IVA) is 145.04%.